Abstract
AbstractThe 13C NMR spectra of a number of pyridazine derivatives have been recorded in DMSO‐d6 solution and analysed. Examination of the most diagnostic resonances, with particular emphasis on those arising from the pyridazine ring system, enabled the ready establishment of the presence of a ring‐chain tautomerism in 5‐(o‐aminophenylcarbamoyl)pyridazine‐4‐carboxylic acid, methyl 5‐(o‐aminophenylcarbamoyl)pyridazine‐4‐carboxylate, 5‐(o‐aminophenylcarbamoyl)‐3,6,‐dimethylpyridazine‐4‐carboxylic acid and 5‐(2‐amino‐1,2‐dicyanovinylenecarbamoyl)pyridazine‐4‐carboxylic acid. This gave rise to 3′,4′‐dihydro‐3′‐oxospiro[pyridazine‐5(2H),2′(1H)‐quinoxaline]‐4‐carboxylic acid, methyl 3′,4′‐dihydro‐3′oxospiro[pyridazine‐5(2H),2′(1′H)‐quinoxaline]‐4‐carboxylate, 3′,4′‐dihydro‐3′‐oxo‐3,6‐dimethylspiro[pyridazine‐5(2H), 2′(1′H)‐quinoxaline]‐4‐carboxylic acid and 5‐oxo‐2,3‐dicyano‐1,4,8,9‐tetraazaspiro[5.5]undeca‐2,7,10‐triene‐11‐carboxylic acid, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
